Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modularly assembled small molecules for the treatment of myotonic dystrophy type 1

Modularly assembled small molecules for the treatment of myotonic dystrophy type 1

US Patent 9795687 · Granted Oct 24, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Transcriptome-wide design of selective, bioactive small molecules targeting RNA2023
Bis-benzimidazole compounds and methods of using the same2021
Bis-benzimidazole compounds and methods of using the same2021
Toxic RNA inhibitors self-assembled in situ2019
Toxic RNA inhibitors self-assembled in situ2019
Treatment of C9FTD/ALS by targeting RNA expanded repeat sequences2019
Toxic RNA inhibitors self-assembled in situ2019
Toxic RNA inhibitors self-assembled in situ2019
Transcriptome-wide design of selective, bioactive small molecules targeting RNA2018
Small molecules targeting repeat r(CGG) sequences2018
Specific targeting of RNA expanded repeat sequences2018
Methods for identifying ligands that target nucleic acid molecules and nucleic a2017